Jornay Pm
Manufacturing · United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.jornaypm.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Jornay Pm
Jornay PM is a medication that contains methylphenidate HCI, designed to help manage symptoms of attention deficit hyperactivity disorder (ADHD). The product is intended for individuals seeking effective treatment options for ADHD. The company focuses on providing solutions that improve the quality of life for those affected by this condition. Jornay PM aims to support patients and healthcare providers in achieving better management of ADHD symptoms.Explore more
Popular SearchesJornay PmJornaySIC Code 28,283NAICS Code 32,325Show moreSell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Jornay Pm your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Jornay Pm has new funding data
Congratulate Masked Content for being promoted to Masked Content at Jornay Pm
Jornay Pm, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Jornay Pm had a recent Job posting/layoffs
Check if Jornay Pm has recently received funding, and reach out quickly before it becomes old news!
Check out if Jornay Pm is spiking on competitors!
Earning: See what the market has to say on Jornay Pm recently announced quarterly report
Product Launch: Get notified when Jornay Pm launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Jornay Pm
Compare insights from companies similar to Jornay Pm, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Jornay Pm
<$5M
1-10
Private
-
-
N/A
Company Profile Activity
Activity Insights
Jornay Pm is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Jornay Pm is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Jornay Pm.
Jornay Pm Tech Stack
A closer look at the technologies used by Jornay Pm
Jornay Pm News & Media
Knight Therapeutics Announces Launch of JORNAY PM™ in Canada
MONTREAL, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today the launch of JORNAY PM™ (methylphenidate HCI extended-release capsules) in Canada. JORNAY PM™ is an extended-release formulation of methylphenidate, a stimulant medication for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in children 6-12 years of age.1Knight Therapeutics Announces Health Canada Approval for JORNAY PM™ to Treat Attention-Deficit Hyperactivity Disorder (ADHD)
MONTREAL, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Health Canada has approved JORNAY PM™, an extended-release formulation of methylphenidate, a stimulant medication for the treatment of Attention-Deficit Hyperactivity Disorder (ADHD) in children.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Jornay Pm
Sign Up For FreeTo access detailed company insights
Jornay PM is a medication that contains methylphenidate HCI, designed to help manage symptoms of attention deficit hyperactivity disorder (ADHD). The product is intended for individuals seeking effective treatment options for ADHD. The company focuses on providing solutions that improve the quality of life for those affected by this condition. Jorn... Read More
